Text Size
35 studies found for:    Open Studies | "Arthritis, Psoriatic"

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Arthritis, Psoriatic" (35 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting A Study to Investigate the Use of Simponi® in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)
Conditions: Arthritis, Rheumatoid;   Arthritis, Psoriatic;   Spondylitis, Ankylosing
Intervention: Drug: Simponi®
2 Recruiting A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
Conditions: Psoriasis;   Arthritis, Psoriatic
Interventions: Drug: CP-690,550;   Drug: CP-690, 550
3 Recruiting Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy
Condition: Arthritis, Psoriatic
Interventions: Biological: Placebo matching BMS-945429;   Biological: BMS-945429
4 Not yet recruiting A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Conditions: Rheumatoid Arthritis;   Psoriatic Arthritis;   Ankylosing Spondylitis
Intervention: Drug: No intervention
5 Unknown † TIght COntrol of Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Intensive management or Tight control;   Drug: Standard management - Control group
6 Recruiting Assessment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients`Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:
7 Recruiting Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic Arthritis
Conditions: Psoriatic Arthritis;   Psoriasis
Intervention:
8 Recruiting Biologic Rheumatology Registry Across Canada
Conditions: Arthritis, Rheumatoid;   Spondylitis, Ankylosing;   Arthritis, Psoriatic
Intervention:
9 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention:
10 Not yet recruiting Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Condition: Psoriatic Arthritis
Interventions: Drug: Tofacitinib 5 mg BID;   Drug: Tofacitinib 10 mg BID;   Drug: Adalimumab;   Drug: Placebo
11 Not yet recruiting Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab (AIN457) in Patients of Active Psoriatic Arthritis (PsA).
Condition: Psoriatic Arthritis
Interventions: Biological: AIN457;   Biological: Placebo
12 Not yet recruiting Psoriatic Arthritis Treat to Target vs. Usual Care
Condition: Psoriatic Arthritis (PsA)
Interventions: Other: Intensive Care;   Other: Routine Care
13 Recruiting PET/CT in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Radiation: FDG-PET/CT scan
14 Not yet recruiting Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Abatacept;   Drug: Placebo matching with Abatacept
15 Recruiting The Effect of n-3 Polyunsaturated Fatty Acids in Patients With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Dietary Supplement: n-3PUFA;   Dietary Supplement: olive oil
16 Not yet recruiting Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium
Conditions: Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:
17 Recruiting Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Conditions: Psoriasis;   Arthritis, Psoriatic
Interventions: Biological: ustekinumab;   Biological: Biological therapies other than infliximab and ustekinumab;   Drug: conventional systemic agents;   Biological: infliximab
18 Not yet recruiting Initial Treatment With Golimumab in Early PsA
Condition: Psoriatic Arthritis
Interventions: Drug: golimumab;   Drug: methotrexate
19 Recruiting National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study
Condition: Psoriatic Arthritis
Interventions: Drug: Methotrexate;   Drug: Anti-TNF
20 Unknown † Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment
Conditions: Rheumatoid Arthritis;   Psoriatic Arthritis;   Ankylosing Spondylitis;   Endothelial Dysfunction;   Inflammatory Disease Activity
Intervention:
To Top

Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results
† Indicates status has not been verified in more than two years